C20H24O7
Neat
376.41
Tripdiolide; 38647-10-8; Triptodiolide; 7VRC678RTA; NSC-163063; DTXSID401045708; Triptolide, 2-hydroxy-, (2beta)-; (1S, 2S, 4S, 5S, 7R, 8R, 9S, 11S, 13S, 19S)-8, 19-dihydroxy-1-methyl-7-propan-2-yl-3, 6, 10, 16-tetraoxaheptacyclo[11.7.0.02, 4.02, 9.05, 7.09, 11.014, 18]icos-14(18)-en-17-one; TRISOXIRENO(4B, 5:6, 7:8A, 9)PHENANTHRO(1, 2-C)FURAN-1(3H)-ONE, 3B, 4, 4A, 6, 6A, 7A, 7B, 8B, 9, 10-DECAHYDRO-6, 10-DIHYDROXY-8B-METHYL-6A-(1-METHYLETHYL)-, (3BS, 4AS, 5AS, 6R, 6AR, 7AS, 7BS, 8AS, 8BS, 10S)-; (2 beta)-2-hydroxytriptolide; ((3aR, 4S, 6S, 6aS, 9aR, 9bR)-6, 9a-dimethyl-3-methylene-2, 9-dioxo-3a, 4, 5, 6, 6a, 7, 8, 9b-octahydroazuleno(4, 5-b)furan-4-yl) acetate; (1S, 2S, 4S, 5S, 7R, 8R, 9S, 11S, 13S, 19S)-8, 19-dihydroxy-1-methyl-7-propan-2-yl-3, 6, 10, 16-tetraoxaheptacyclo(11.7.0.02, 4.02, 9.05, 7.09, 11.014, 18)icos-14(18)-en-17-one; RefChem:191877; DTXCID801527635; Tripdiolid; NSC163063; Triptolide, 2-hydroxy- and (2-beta)-; (2beta)-2-Hydroxytriptolide; UNII-7VRC678RTA; NSC 163063
(1S, 2S, 4S, 5S, 7R, 8R, 9S, 11S, 13S, 19S)-8, 19-dihydroxy-1-methyl-7-propan-2-yl-3, 6, 10, 16-tetraoxaheptacyclo[11.7.0.02, 4.02, 9.05, 7.09, 11.014 and 18]icos-14(18)-en-17-one
InChI=1S/C20H24O7/c1-7(2)18-13(26-18)14-20(27-14)17(3)5-10(21)12-8(6-24-15(12)22)9(17)4-11-19(20,25-11)16(18)23/h7,9-11,13-14,16,21,23H,4-6H2,1-3H3/t9-,10-,11-,13-,14-,16+,17-,18-,19+,20+/m0/s1